Global Commercialization Director, Glomerulonephropathy (GN)

The Global Commercialization Director for Glomerulonephropathy (GN) leads the commercial strategy and global launch plans for GN indications, including IgAN and PMN, within Biogen's Nephrology Product Development and Commercialization team. This role involves driving long-term success by developing integrated cross-functional strategies, executing evidence generation, and engaging with medical experts, patient communities, and policymakers. The position requires coordinating with regional teams and global leads to ensure market readiness, optimize asset value, and achieve sustainable growth across international markets.